Clinical Trials
2 trialsNCT01959282 2019-01-04
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Janssen Research & Development, LLC
Phase 2 Completed
NCT00584740 2015-03-31
Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn's Disease
Novartis
Phase 2 Terminated